BenzingaAugust 18, 2026 at 5:58 AM NY2 Months Ago
UBS Maintains Neutral on Corteva, Lowers Price Target to $85
UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $89 to $85.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
